Gene · 406931
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37790603 | PubTator, text mining | PubMed |
| Emerging Roles of Using Small Extracellular Vesicles as an Anti-Cancer Drug. | Int J Mol Sci | 2023 | 37762393 | PubTator, text mining | PubMed |
| MicroRNAs in the Regulation of RIG-I-like Receptor Signaling Pathway: Possible Strategy for Viral Infection and Cancer. | Biomolecules | 2023 | 37759744 | PubTator, text mining | PubMed |
| Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer. | Genes Immun | 2023 | 37759086 | PubTator, text mining | PubMed |
| Bioinformatics analysis to reveal the potential comorbidity mechanism in psoriasis and nonalcoholic steatohepatitis. | Skin Res Technol | 2023 | 37753698 | PubTator, text mining | PubMed |
| circELMOD3 increases and stabilizes TRIM13 by sponging miR-6864-5p and direct binding to inhibit HCC progression. | iScience | 2023 | 37752955 | PubTator, text mining | PubMed |
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. | Cell Death Dis | 2023 | 37749143 | PubTator, text mining | PubMed |
| Integrated analysis of SKA1-related ceRNA network and SKA1 immunoassays in HCC: A study based on bioinformatic. | Medicine (Baltimore) | 2023 | 37746945 | PubTator, text mining | PubMed |
| The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review. | Noncoding RNA | 2023 | 37736900 | PubTator, text mining | PubMed |
| Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs. | J Transl Med | 2023 | 37715207 | PubTator, text mining | PubMed |
| MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected. | J Mol Med (Berl) | 2023 | 37704856 | PubTator, text mining | PubMed |
| A simple and efficient strategy for cell-based and cell-free-based therapies in acute liver failure: hUCMSCs bioartificial liver. | Bioeng Transl Med | 2023 | 37693041 | PubTator, text mining | PubMed |
| EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis. | Cancer Cell Int | 2023 | 37689710 | PubTator, text mining | PubMed |
| Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development. | Cancers (Basel) | 2023 | 37686592 | PubTator, text mining | PubMed |
| Common miRNAs of Osteoporosis and Fibromyalgia: A Review. | Int J Mol Sci | 2023 | 37686318 | PubTator, text mining | PubMed |
| Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges. | Int J Mol Sci | 2023 | 37686149 | PubTator, text mining | PubMed |
| The regulatory role of cancer stem cell marker gene CXCR4 in the growth and metastasis of gastric cancer. | NPJ Precis Oncol | 2023 | 37679408 | PubTator, text mining | PubMed |
| Retinoic acid-inducible gene-I like receptor pathway in cancer: modification and treatment. | Front Immunol | 2023 | 37662910 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. | J Transl Med | 2023 | 37660060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406931/papers?page=7